Germany · Delayed Price · Currency is EUR Global Bioenergies Statistics
Total Valuation
FRA:1DK has a market cap or net worth of EUR 335,375. The enterprise value is 1.13 million.
| Market Cap | 335,375 |
| Enterprise Value | 1.13M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 18.13M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -3.00% |
| Owned by Insiders (%) | 2.68% |
| Owned by Institutions (%) | 3.47% |
| Float | 15.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.93 |
| PB Ratio | 0.20 |
| P/TBV Ratio | 0.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.19 |
| EV / Sales | 3.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.14 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 3.34.
| Current Ratio | 1.43 |
| Quick Ratio | 1.11 |
| Debt / Equity | 3.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.71 |
| Interest Coverage | -22.55 |
Financial Efficiency
Return on equity (ROE) is -96.88% and return on invested capital (ROIC) is -37.34%.
| Return on Equity (ROE) | -96.88% |
| Return on Assets (ROA) | -30.21% |
| Return on Invested Capital (ROIC) | -37.34% |
| Return on Capital Employed (ROCE) | -189.80% |
| Revenue Per Employee | 8,388 |
| Profits Per Employee | -136,302 |
| Employee Count | 43 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 1.75 |
Taxes
| Income Tax | -1.25M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.63% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -97.63% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.45 |
| Relative Strength Index (RSI) | 49.64 |
| Average Volume (20 Days) | 3,122 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:1DK had revenue of EUR 360,664 and -5.86 million in losses. Loss per share was -0.32.
| Revenue | 360,664 |
| Gross Profit | -488,517 |
| Operating Income | -6.74M |
| Pretax Income | -7.11M |
| Net Income | -5.86M |
| EBITDA | -4.24M |
| EBIT | -6.74M |
| Loss Per Share | -0.32 |
Balance Sheet
The company has 4.86 million in cash and 5.65 million in debt, with a net cash position of -791,272.
| Cash & Cash Equivalents | 4.86M |
| Total Debt | 5.65M |
| Net Cash | -791,272 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.69M |
| Book Value Per Share | 0.09 |
| Working Capital | 2.65M |
Cash Flow
In the last 12 months, operating cash flow was -7.51 million and capital expenditures -466,367, giving a free cash flow of -7.97 million.
| Operating Cash Flow | -7.51M |
| Capital Expenditures | -466,367 |
| Free Cash Flow | -7.97M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -135.45% |
| Operating Margin | -1,869.85% |
| Pretax Margin | -1,971.99% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:1DK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.56% |
| Shareholder Yield | -1.56% |
| Earnings Yield | -1,747.60% |
| FCF Yield | -2,377.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:1DK has an Altman Z-Score of -0.6 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.6 |
| Piotroski F-Score | 1 |